BIOMAT Database Logo BIOMAT Database Logo

Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination. 2018

George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Division of Gastroenterology, Department of Medicine, East Carolina University, Greenville, NC, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
January 2002, Transplant international : official journal of the European Society for Organ Transplantation,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
After Curing Hepatitis C Virus Infection.
May 2018, Annals of internal medicine,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
After Curing Hepatitis C Virus Infection.
May 2018, Annals of internal medicine,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.
January 1991, Annals of hematology,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Perspectives of hepatitis C virus (HCV) elimination in Poland.
September 2019, Clinical and experimental hepatology,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C, interferon, and risk of rejection after liver transplantation.
July 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C virus and organ transplantation.
July 1996, Transplantation,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C virus and organ transplantation.
February 1993, The New England journal of medicine,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C virus and organ transplantation.
February 1993, The New England journal of medicine,
George Kasarala, and Steve Choi, and Katie Lopez, and Rachel B Britt, and Colleen Boatright, and Hans L Tillmann
Hepatitis C virus and organ transplantation.
February 1993, The New England journal of medicine,
Copied contents to your clipboard!